Gene · 5889
Papers3,668
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,001 to 1,020 of 3,668
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Inhibition of the Translation Initiation Factor eIF4A Enhances Tumor Cell Radiosensitivity. | Mol Cancer Ther | 2022 | 35732578 | PubTator, text mining | PubMed |
| Targeting Therapeutic Resistance and Multinucleate Giant Cells in CCNE1-Amplified HR-Proficient Ovarian Cancer. | Mol Cancer Ther | 2022 | 35732503 | PubTator, text mining | PubMed |
| Polyphenols from persimmon fruit attenuate acetaldehyde-induced DNA double-strand breaks by scavenging acetaldehyde. | Sci Rep | 2022 | 35717470 | PubTator, text mining | PubMed |
| Minigene-based splicing analysis and ACMG/AMP-based tentative classification of 56 ATM variants. | J Pathol | 2022 | 35716007 | PubTator, text mining | PubMed |
| CRISPR/Cas9‑induced saturated mutagenesis identifies Rad51 haplotype as a marker of PARP inhibitor sensitivity in breast cancer. | Mol Med Rep | 2022 | 35713220 | PubTator, text mining | PubMed |
Spectrum of germline pathogenic variants using a targeted next generation sequencing panel and genotype-phenotype correlations in patients with suspected hereditary breast cancer at an academic medical centre in Pakistan. | Hered Cancer Clin Pract | 2022 | 35710434 | PubTator, text mining | PubMed |
| Comprehensive Analysis of the Expression and Prognostic Value of LMAN2 in HER2+ Breast Cancer. | J Immunol Res | 2022 | 35707004 | PubTator, text mining | PubMed |
| A pan-cancer compendium of chromosomal instability. | Nature | 2022 | 35705807 | PubTator, text mining | PubMed |
| Signatures of copy number alterations in human cancer. | Nature | 2022 | 35705804 | PubTator, text mining | PubMed |
| Pilot Study: PARP1 Imaging in Advanced Prostate Cancer. | Mol Imaging Biol | 2022 | 35701722 | PubTator, text mining | PubMed |
| Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification. | Clin Cancer Res | 2022 | 35696721 | PubTator, text mining | PubMed |
| Identification of Novel circRNA-Based ceRNA Network Involved in the Pathogenesis of Gastric Cancer. | Int J Genomics | 2022 | 35685832 | PubTator, text mining | PubMed |
| Mutational landscape of gastric adenocarcinoma in Latin America: A genetic approach for precision medicine. | Genes Dis | 2022 | 35685475 | PubTator, text mining | PubMed |
| Tissue-Based Markers as a Tool to Assess Response to Neoadjuvant Radiotherapy in Rectal Cancer-Systematic Review. | Int J Mol Sci | 2022 | 35682714 | PubTator, text mining | PubMed |
| Insights into the Possible Molecular Mechanisms of Resistance to PARP Inhibitors. | Cancers (Basel) | 2022 | 35681784 | PubTator, text mining | PubMed |
| Are Mutation Carrier Patients Different from Non-Carrier Patients? Genetic, Pathology, and US Features of Patients with Breast Cancer. | Cancers (Basel) | 2022 | 35681739 | PubTator, text mining | PubMed |
| Pan-cancer analysis of genomic scar patterns caused by homologous repair deficiency (HRD). | NPJ Precis Oncol | 2022 | 35681079 | PubTator, text mining | PubMed |
| Risk-reducing surgery in unaffected individuals receiving cancer genetic testing in an integrated health care system. | Cancer | 2022 | 35679147 | PubTator, text mining | PubMed |
| Complete response to pembrolizumab in a patient with dermatomyositis and MMR deficient ovarian cancer: A case report. | Gynecol Oncol Rep | 2022 | 35663849 | PubTator, text mining | PubMed |
| Functional RECAP (REpair CAPacity) assay identifies homologous recombination deficiency undetected by DNA-based BRCAness tests. | Oncogene | 2022 | 35662281 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5889/papers?page=51